Report overview
Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.
This report aims to provide a comprehensive presentation of the global market for Next Generation Diabetes Therapy and Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Diabetes Therapy and Drug Delivery. This report contains market size and forecasts of Next Generation Diabetes Therapy and Drug Delivery in global, including the following market information:
Global Next Generation Diabetes Therapy and Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Next Generation Diabetes Therapy and Drug Delivery market was valued at US$ 1808.7 million in 2022 and is projected to reach US$ 7401.3 million by 2029, at a CAGR of 22.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The market growth is attributed to the rise in the number of diabetic patients globally and the increase in disposable income among these patients. The benefits of using these advanced devices over conventional products, such as painless mode of insulin delivery and improvement in adherence to medication, and rise in the healthcare expenditure are expected to increase the demand for these products, thus fueling the market growth. However, lack of awareness, cost restrains in the developing regions, and less variability in products are expected to hamper the growth.
We surveyed the Next Generation Diabetes Therapy and Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Next Generation Diabetes Therapy and Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Next Generation Diabetes Therapy and Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Global Next Generation Diabetes Therapy and Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Next Generation Diabetes Therapy and Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Diagnostic/Clinics
ICUs
Home Healthcare
Global Next Generation Diabetes Therapy and Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Next Generation Diabetes Therapy and Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next Generation Diabetes Therapy and Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Next Generation Diabetes Therapy and Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics
Medtech
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next Generation Diabetes Therapy and Drug Delivery, market overview.
Chapter 2: Global Next Generation Diabetes Therapy and Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Next Generation Diabetes Therapy and Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next Generation Diabetes Therapy and Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
